NEW YORK ( TheStreet) -- ADVENTRX Pharmaceuticals (AMEX: ANX) hit a new 52-week low Wednesday as it is currently trading at $1.04, below its previous 52-week low of $1.73 with 1.5 million shares traded as of 9:38 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.

ADVENTRX has a market cap of $55.3 million and is part of the health care sector and drugs industry. Shares are down 19.9% year to date as of the close of trading on Tuesday.

ADVENTRX Pharmaceuticals, Inc., specialty pharmaceutical company, focuses on acquiring, developing, and commercializing proprietary product candidates. Its lead products include Exelbine or ANX-530, an emulsion formulation of the chemotherapy drug vinorelbine.
  • Practice your ANX trading strategies and win cash in our stock game.

TheStreet Ratings rates ADVENTRX as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and poor profit margins. You can view the full ADVENTRX Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.